Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00344890 · ClinicalTrials.gov registry record · NA

Safety Study of Preservon-Treated Bone Implants for Cervical Fusion in the Treatment of Cervical Radiculopathy or Myelopathy

A NA study, sponsored by LifeNet Health.

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT00344890: Completed NA study, sponsored by LifeNet Health.

NCT00344890 is a NA study that has completed, run by LifeNet Health. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00344890, a NA study, has completed, sponsored by LifeNet Health.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

The purpose of this study is to compare the safety and efficacy of Preservon(TM) treated allograft bone dowels to traditional freeze-dried allograft bone dowels (control) for fusion of degenerated cervical intervertebral discs in the treatment of cervical radiculopathy or myelopathy. Patient follow-up will be conducted at 6 weeks, 3 months, and 6 months. At 3 months after surgery, the implanted bone dowels will be assessed for subsidence; at 6 months after surgery, the implanted bone dowels will be assessed for fusion. Patients will complete questionnaires and x-rays taken at each visit. The degree of subsidence and rate of fusion will be assessed based on the evaluation of the x-rays taken. The x-ray evaluation will be conducted by a neurosurgeon who is blinded to the type of treatment that each patient has received.

Interventions

  • PROCEDURE Anterior Cervical Discectomy and Fusion

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2006-09
Est. Completion 2012-12
Phase NA
LifeNet Health

8 total trials

What the finished NCT00344890 record still lists

NCT00344890 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Anterior Cervical Discectomy and Fusion is the first listed.

NCT00344890 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00344890 about?

NCT00344890 is a clinical study titled "Safety Study of Preservon-Treated Bone Implants for Cervical Fusion in the Treatment of Cervical Radiculopathy or Myelopathy". The purpose of this study is to compare the safety and efficacy of Preservon(TM) treated allograft bone dowels to traditional freeze-dried allograft bone dowels (control) for fusion of degenerated cervical intervertebral discs in the treatment of cervical radiculopathy or myelopathy. Patient follow...

What is the current status of trial NCT00344890?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2006-09. Estimated completion is 2012-12.

What interventions are being tested in trial NCT00344890?

The interventions under investigation include: Anterior Cervical Discectomy and Fusion (PROCEDURE).

Who is sponsoring clinical trial NCT00344890?

This trial is sponsored by LifeNet Health, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00344890's enrollment target sits among peer trials

106 830th of 2000 higher than 1,167 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00344890, the US trial registry maintained by the National Library of Medicine. NCT00344890 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.